A randomised evaluation trial of the Life Flex digital health program for anxiety and depressive symptoms.

Not Applicable

Suspended

• Conditions: Anxiety; Depression; Mental Health - Anxiety; Mental Health - Depression

• Registration Number: ACTRN12622000865718
• Lead Sponsor: Federation University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-06-17
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Suspended
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Participants must be 18 years or older, reside in Australia and concerned about their anxiety and or depressive symptoms.

Exclusion Criteria

No internet access, does not create a HealthZone account (requires the provision of a valid email address), does not provide consent to study conditions.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety symptoms using the Generalised Anxiety Disorder-7 (GAD-7) survey[ Pre-intervention (Week 0), during intervention (Week 3, 5, 7), post (week 9, primary endpoint) and 3 month follow-up (Week 21).];Depressive symptoms using the Patient Health Questionnaire-8 (PHQ-8)[ Pre-intervention (Week 0), during intervention (Week 3, 5, 7), post (week 9, primary endpoint) and 3 month follow-up (Week 21).]